Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The Cathinone Hydra: Increased Cathinone and caffeine adulteration in the English MDMA market after Brexit and COVID-19 lockdowns
Michael Pascoe, Sarah Radley, Henry Simmons, et al.
Drug Science Policy and Law (2022) Vol. 8
Open Access | Times Cited: 21

Showing 21 citing articles:

Three years of wastewater surveillance for new psychoactive substances from 16 countries
Richard Bade, Nikolaos I. Rousis, Sangeet Adhikari, et al.
Water Research X (2023) Vol. 19, pp. 100179-100179
Open Access | Times Cited: 32
What is drug checking, anyway?
Monica J. Barratt, Fiona Measham
Drugs Habits and Social Policy (2022) Vol. 23, Iss. 3, pp. 176-187
Closed Access | Times Cited: 34
Amphetamine-type stimulants and phenethylamines in the landscape of new psychoactive substances
Aline Thaís Bruni, Caio Henrique Pinke Rodrigues, Lívia Salviano Mariotto, et al.
Comprehensive analytical chemistry (2025)
Closed Access
Risk communication about high‐dose MDMA: Impact of a hypothetical drug alert on future MDMA use
Joel Keygan, Breanna Willoughby, Raimondo Bruno, et al.
Drug and Alcohol Review (2025)
Open Access
Analysis of the UK Government’s 10-Year Drugs Strategy—a resource for practitioners and policymakers
Adam Holland, Alex Stevens, Magdalena Harris, et al.
Journal of Public Health (2022) Vol. 45, Iss. 2, pp. e215-e224
Open Access | Times Cited: 18
Characterising differences between self-reported and wastewater-identified drug use at two consecutive years of an Australian music festival
Cheneal Puljević, Benjamin J. Tscharke, Ellen Leslie, et al.
The Science of The Total Environment (2024) Vol. 921, pp. 170934-170934
Open Access | Times Cited: 3
Harm reduction behaviours and harm experiences of people who use 3,4-methylenedioxymethamphetamine (MDMA) in Aotearoa New Zealand
Jai Whelan, Geoff Noller, Ryan D. Ward
Harm Reduction Journal (2024) Vol. 21, Iss. 1
Open Access | Times Cited: 3
Instrument-independent chemometric models for rapid, calibration-free NPS isomer differentiation from mass spectral GC-MS data
Jennifer L. Bonetti, Ruben F. Kranenburg, Esmee Schoonderwoerd, et al.
Forensic Science International (2023) Vol. 348, pp. 111650-111650
Open Access | Times Cited: 7
Acute, chronic, and post-mortem toxicity: a review focused on three different classes of new psychoactive substances
Caio Henrique Pinke Rodrigues, Lívia Salviano Mariotto, Jade Simões Castro, et al.
Forensic Toxicology (2023) Vol. 41, Iss. 2, pp. 187-212
Closed Access | Times Cited: 6
Detected substance abuse among injecting drug users through analysis of used syringes in Tunisia
Bilel Moslah, Omar Smaoui, Thomas Néfau, et al.
Forensic Science International (2024) Vol. 365, pp. 112299-112299
Closed Access | Times Cited: 1
Drug policing down under: An investigation of panic consumption, internal concealment and the use of drug amnesty bins among a sample of Australian festivalgoers
Jodie Grigg, Monica J. Barratt, Simon Lenton
International Journal of Drug Policy (2022) Vol. 106, pp. 103769-103769
Closed Access | Times Cited: 7
Size matters: comparing the MDMA content and weight of ecstasy tablets submitted to European drug checking services in 2012–2021
Ruben Q. Vrolijk, Fiona Measham, Adrià Quesada, et al.
Drugs Habits and Social Policy (2022) Vol. 23, Iss. 3, pp. 207-219
Closed Access | Times Cited: 6
Échele Cabeza as a harm reduction project and activist movement in Colombia
Mauro Díaz Moreno, Nathalia Alarcón Ayala, Yarelix Estrada, et al.
Drugs Habits and Social Policy (2022) Vol. 23, Iss. 3, pp. 263-276
Closed Access | Times Cited: 4
Challenges, policy and politics in drug checking: reflections of the TEDItorial team
Nicolas Van der Linden, Raoul Pieter Joost Koning, Daan van der Gouwe, et al.
Drugs Habits and Social Policy (2022) Vol. 23, Iss. 3, pp. 289-302
Closed Access | Times Cited: 4
A rapid scoping review of harm reduction strategies for ecstasy (MDMA) users in recreational settings
Deborah Edwards, Judit Csontos, Michael Pascoe, et al.
Research Square (Research Square) (2024)
Open Access
“I knew where help was.” Identifying Substance Use Patterns, Associated Predictors of Harm, and Barriers to Help Seeking among Music Festival Attendees: The Development of a Targeted Harm Reduction Intervention
Chloe L. Rayner
(2024)
Open Access
A thematic analysis of MDMA-related harm and harm reduction experiences and knowledge in Aotearoa New Zealand
Jai Whelan, Ryan D. Ward, Geoff Noller
Harm Reduction Journal (2024) Vol. 21, Iss. 1
Open Access
Novel harm reduction measures at music festivals in Australia: Pilot implementation of the Emerging Drugs Network of Australia–Victoria toxicosurveillance methodology
Rebekka Syrjanen, Martin Dutch, Shaun L. Greene, et al.
Drug and Alcohol Review (2024) Vol. 43, Iss. 7, pp. 2045-2054
Open Access
Counting and accounting for drug-related deaths at UK music festivals 2017–2023: A commentary
Tom Cooney, Fiona Measham
Drug Science Policy and Law (2023) Vol. 9
Open Access | Times Cited: 1
A rapid scoping review of harm reduction strategies for ecstasy (MDMA) users in recreational settings
Deborah Edwards, Judit Csontos, Michael Pascoe, et al.
Research Square (Research Square) (2022)
Open Access | Times Cited: 1
A rapid scoping review of self-initiated harm reduction strategies for ecstasy (MDMA) users in recreational settings
Deborah Edwards, Judit Csontos, Michael Pascoe, et al.
Research Square (Research Square) (2023)
Open Access
Page 1

Scroll to top